Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
29,149,043
-
Total 13F shares
-
14,626,888
-
Share change
-
-545,198
-
Total reported value
-
$483,060,372
-
Put/Call ratio
-
812%
-
Price per share
-
$33.02
-
Number of holders
-
132
-
Value change
-
-$21,919,941
-
Number of buys
-
66
-
Number of sells
-
67
Institutional Holders of ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) as of Q4 2015
As of 31 Dec 2015,
ENANTA PHARMACEUTICALS INC - Common Stock, par value $0.01 per share (ENTA) was held by
132 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,626,888 shares.
The largest 10 holders included
Apex Capital Management, BlackRock Fund Advisors, EAGLE ASSET MANAGEMENT INC, Krensavage Asset Management, LLC, ACADIAN ASSET MANAGEMENT LLC, FMR LLC, Invesco Ltd., VANGUARD GROUP INC, STATE STREET CORP, and ORBIMED ADVISORS LLC.
This page lists
132
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.